Diagnostics Market Research
Explore your competitors and realise your potential in the Diagnostics market. Our reports include information on Testing, Companion Markets, Imaging and In Vitro Diagnostics.
Stay up-to-date with new products added to this category
previous
Title  | Date  | Price |
|---|---|---|
| Competitor Analysis: Coagulation Factors | Oct 2009 | £450 |
| Competitor Analysis VEGF and VEGF-R Agonists and Antagonists | Sep 2009 | £540 |
| UK Diagnostic Imaging Market Analysis and Forecasts to 2015 | Sep 2009 | £2,135 |
| Advanced Digital Diagnostic Medical Imaging Equipment Market Analysis & Directions | Sep 2009 | £1,540 |
| U.S. DNA-Based Diagnostic Test and Equipment Market Analysis & Directions Market Trends, New Product Trends, Technology Trends, Distribution Structure and 15 Notable Company Case Studies | Sep 2009 | £1,880 |
| Innovations in Medical Imaging Technological Advances, Growth Opportunities and Future Market Outlook | Aug 2009 | £2,340 |
| Global Molecular Diagnostics Market Opportunities & Future Forecast | Aug 2009 | £610 |
| Infectious Disease Diagnostic Markets | Aug 2009 | £2,135 |
| Coagulation Factors 2009 Target Pipeline and Corporate Benchmark Analysis | Aug 2009 | £2,215 |
| CEO 360 Degree Perspective - Global Clinical Diagnostics Industry | Aug 2009 | £3,660 |
| Diagnostic & Medical Laboratories in the US IBISWorld Industry Report | Aug 2009 | £395 |
| Over-the-Counter Diagnostic Products World Markets | Aug 2009 | £2,140 |
| What Is Working in IVD Successful Commercialization of New Products and Technologies | Jul 2009 | £1,525 |
| Strategic Analysis of U.S. Drugs of Abuse Laboratory Testing | Jul 2009 | £3,660 |
| Medical Ultrasound Systems Market Worldwide. 2009 | Jul 2009 | £1,520 |
| Molecular Diagnostics Market: Trends and Opportunities | Jul 2009 | £485 |
| Medical Imaging Markets | Jun 2009 | £2,105 |
| The Top 40 Manufacturers Of Diagnostic Imaging Equipment In Europe | Jun 2009 | £250 |
| U.S. Market for Diagnostic Opthalmic Devices 2009 | Jun 2009 | £4,570 |
| Point of Care Diagnostic Testing Sector Trends | Jun 2009 | £2,105 |
| Point of Care Diagnostic Testing World Markets | Jun 2009 | £2,050 |
| Brazil Diagnostic Imaging Investment Opportunities, Analysis and Forecasts to 2015 | Jun 2009 | £1,545 |
| China Diagnostic Imaging Investment Opportunities, Analysis and Forecasts to 2015 | Jun 2009 | £1,545 |
| Global Diagnostic Imaging Investment Opportunities, Analysis and Forecasts to 2015 | Jun 2009 | £2,475 |
| The Top 100 Point-Of-Care Manufacturing Companies Worldwide Second Edition | May 2009 | £630 |
| Strategic Analysis of the European Markets for Theranostics | May 2009 | £3,965 |
| Cystic Fibrosis, Mucoviscoidosis NA Tests in UK Assessment of the Molecular Diagnostic Market | Apr 2009 | £360 |
| Chlamydia trachomatis/Neisseria gonorrheae (CT/NG) NA Tests in UK Assessment of the Molecular Diagnostic Market | Apr 2009 | £360 |
| RSV NA Tests in Germany Assessment of the Molecular Diagnostic Market | Apr 2009 | £360 |
| VRE NA Tests in Germany Assessment of the Molecular Diagnostic Market | Apr 2009 | £360 |
| Warfarin sensitivity (CYP2C9, VKOR1) NA Tests in Spain Assessment of the Molecular Diagnostic Market | Apr 2009 | £360 |
| Adenovirus NA Tests in France Assessment of the Molecular Diagnostic Market | Apr 2009 | £360 |
| Neisseria Gonorrheae (NG) NA Tests in Germany Assessment of the Molecular Diagnostic Market | Apr 2009 | £360 |
| Parainfluenza 1, 2, 3 NA Tests in Germany Assessment of the Molecular Diagnostic Market | Apr 2009 | £360 |
| Mycobacterium Tuberculosis Direct (MTD) NA Tests in Spain Assessment of the Molecular Diagnostic Market | Apr 2009 | £360 |
| VZV NA Tests in Germany Assessment of the Molecular Diagnostic Market | Apr 2009 | £360 |
| Warfarin sensitivity (CYP2C9, VKOR1) NA Tests in Germany Assessment of the Molecular Diagnostic Market | Apr 2009 | £360 |
| Staphylococcus aureus NA Tests in Germany Assessment of the Molecular Diagnostic Market | Apr 2009 | £360 |
| Clostridium Difficile (C.diff) NA Tests in France Assessment of the Molecular Diagnostic Market | Apr 2009 | £360 |
| Influenca A/B NA Tests in Spain Assessment of the Molecular Diagnostic Market | Apr 2009 | £360 |
| Human Metapneumovirus (hMPV) NA Tests in Spain Assessment of the Molecular Diagnostic Market | Apr 2009 | £360 |
| CMV Quant NA Tests in France Assessment of the Molecular Diagnostic Market | Apr 2009 | £360 |
| BK Virus NA Tests in France Assessment of the Molecular Diagnostic Market | Apr 2009 | £360 |
| Parainfluenza 1, 2, 3 NA Tests in Spain Assessment of the Molecular Diagnostic Market | Apr 2009 | £360 |
| Chlamydia Trachomatis (CT) NA Tests in France Assessment of the Molecular Diagnostic Market | Apr 2009 | £360 |
| Group B Streptococcus (GBS) NA Tests in France Assessment of the Molecular Diagnostic Market | Apr 2009 | £360 |
| Staphylococcus aureus NA Tests in Spain Assessment of the Molecular Diagnostic Market | Apr 2009 | £360 |
| Fragile X NA Tests in France Assessment of the Molecular Diagnostic Market | Apr 2009 | £360 |
| HIV Qualitative NA Tests in Spain Assessment of the Molecular Diagnostic Market | Apr 2009 | £360 |
| CMF Viral Load NA Tests in France Assessment of the Molecular Diagnostic Market | Apr 2009 | £360 |
| HCV Viral Load NA Tests in Spain Assessment of the Molecular Diagnostic Market | Apr 2009 | £360 |
| Enterovirus NA Tests in France Assessment of the Molecular Diagnostic Market | Apr 2009 | £360 |
| RSV NA Tests in UK Assessment of the Molecular Diagnostic Market | Apr 2009 | £360 |
| CMV Quant NA Tests in UK Assessment of the Molecular Diagnostic Market | Apr 2009 | £360 |
| CMF Viral Load NA Tests in UK Assessment of the Molecular Diagnostic Market | Apr 2009 | £360 |
| Factor V Leiden NA Tests in France Assessment of the Molecular Diagnostic Market | Apr 2009 | £360 |
| Factor V Leiden NA Tests in Spain Assessment of the Molecular Diagnostic Market | Apr 2009 | £360 |
| Chlamydia trachomatis/Neisseria gonorrheae (CT/NG) NA Tests in France Assessment of the Molecular Diagnostic Market | Apr 2009 | £360 |
| HBV Ressistance NA Tests in Spain Assessment of the Molecular Diagnostic Market | Apr 2009 | £360 |
| Factor II NA Tests in France Assessment of the Molecular Diagnostic Market | Apr 2009 | £360 |
| Chlamydia Trachomatis (CT) NA Tests in UK Assessment of the Molecular Diagnostic Market | Apr 2009 | £360 |
| HIV Viral Load NA Tests in UK Assessment of the Molecular Diagnostic Market | Apr 2009 | £360 |
| Cystic Fibrosis, Mucoviscoidosis NA Tests in France Assessment of the Molecular Diagnostic Market | Apr 2009 | £360 |
| Human Metapneumovirus (hMPV) NA Tests in France Assessment of the Molecular Diagnostic Market | Apr 2009 | £360 |
| HCV Genotyping NA Tests in France Assessment of the Molecular Diagnostic Market | Apr 2009 | £360 |
| HBV Viral Load NA Tests in France Assessment of the Molecular Diagnostic Market | Apr 2009 | £360 |
| Chlamydia trachomatis/Neisseria gonorrheae (CT/NG) NA Tests in Spain Assessment of the Molecular Diagnostic Market | Apr 2009 | £360 |
| Adenovirus NA Tests in Spain Assessment of the Molecular Diagnostic Market | Apr 2009 | £360 |
| HCV Qualitative NA Tests in France Assessment of the Molecular Diagnostic Market | Apr 2009 | £360 |
| Mycobacterium Tuberculosis Direct (MTD) NA Tests in Italy Assessment of the Molecular Diagnostic Market | Apr 2009 | £360 |
| Her2Neu NA Tests in France Assessment of the Molecular Diagnostic Market | Apr 2009 | £360 |
| HBV Quantitative NA Tests in France Assessment of the Molecular Diagnostic Market | Apr 2009 | £360 |
| Staphylococcus aureus NA Tests in Italy Assessment of the Molecular Diagnostic Market | Apr 2009 | £360 |
| HCV Viral Load NA Tests in France Assessment of the Molecular Diagnostic Market | Apr 2009 | £360 |
| HCV Qualitative NA Tests in Spain Assessment of the Molecular Diagnostic Market | Apr 2009 | £360 |
| HIV Viral Load NA Tests in France Assessment of the Molecular Diagnostic Market | Apr 2009 | £360 |
| Epstein-Barr Virus (EBV) NA Tests in Spain Assessment of the Molecular Diagnostic Market | Apr 2009 | £360 |
| Enterovirus NA Tests in Spain Assessment of the Molecular Diagnostic Market | Apr 2009 | £360 |
| Cystic Fibrosis, Mucoviscoidosis NA Tests in Spain Assessment of the Molecular Diagnostic Market | Apr 2009 | £360 |
| Warfarin sensitivity (CYP2C9, VKOR1) NA Tests in Italy Assessment of the Molecular Diagnostic Market | Apr 2009 | £360 |
| HBV Ressistance NA Tests in France Assessment of the Molecular Diagnostic Market | Apr 2009 | £360 |
| HIV Qualitative NA Tests in France Assessment of the Molecular Diagnostic Market | Apr 2009 | £360 |
| HCV Viral Load NA Tests in Italy Assessment of the Molecular Diagnostic Market | Apr 2009 | £360 |
| Human Metapneumovirus (hMPV) NA Tests in Italy Assessment of the Molecular Diagnostic Market | Apr 2009 | £360 |
| HLA Typing NA Tests in France Assessment of the Molecular Diagnostic Market | Apr 2009 | £360 |
| HPV Quantitative NA Tests in France Assessment of the Molecular Diagnostic Market | Apr 2009 | £360 |
| HPV Genotyping NA Tests in France Assessment of the Molecular Diagnostic Market | Apr 2009 | £360 |
| HIV Genotyping NA Tests in France Assessment of the Molecular Diagnostic Market | Apr 2009 | £360 |
| HIV Qualitative NA Tests in Italy Assessment of the Molecular Diagnostic Market | Apr 2009 | £360 |
| Neisseria Gonorrheae (NG) NA Tests in Italy Assessment of the Molecular Diagnostic Market | Apr 2009 | £360 |
| Influenca A/B NA Tests in Italy Assessment of the Molecular Diagnostic Market | Apr 2009 | £360 |
| Parainfluenza 1, 2, 3 NA Tests in Italy Assessment of the Molecular Diagnostic Market | Apr 2009 | £360 |
| MRSA NA Tests in France Assessment of the Molecular Diagnostic Market | Apr 2009 | £360 |
| HCV Qualitative NA Tests in Italy Assessment of the Molecular Diagnostic Market | Apr 2009 | £360 |
| MAC NA Tests in France Assessment of the Molecular Diagnostic Market | Apr 2009 | £360 |
| HSV 2 NA Tests in France Assessment of the Molecular Diagnostic Market | Apr 2009 | £360 |
| Influenca A/B NA Tests in France Assessment of the Molecular Diagnostic Market | Apr 2009 | £360 |
| HSV 1 NA Tests in France Assessment of the Molecular Diagnostic Market | Apr 2009 | £360 |
| HPV Quantitative NA Tests in Italy Assessment of the Molecular Diagnostic Market | Apr 2009 | £360 |
| Group A Streptococcus (GAS) NA Tests in France Assessment of the Molecular Diagnostic Market | Apr 2009 | £360 |
Filter Results by
Industry Events
2nd International Conference on Drug Discovery and Therapy
01 Feb 10 to 04 Feb 10
Dubai, United Arab Emirates
view summary >>
Pharma & Healthcare
- Animal / Veterinary
- Biotechnology
- Cardiovascular
- Company Financials
- Company Reports (Pharmaceutical)
- Country Reports (Pharmaceutical)
- Deals & Alliances
- Dental
- Diagnostics
- Dietary
- Diseases
- Drug Delivery
- Drug Discovery
- Finance / Investment
- General Industry
- Generic Drugs
- Healthcare
- IT & eHealth
- Management / Strategy
- Medical Devices
- Medical Supplies
- OTC drugs
- Pharma Chemicals
- Pharmacy
- Prescription Drugs
- Production / Manufacturing
- Regulation & Policy
- Research (R&D)
- Sales & Marketing
- Technology
- Therapeutic
- Treatments
call +44 (0) 20 7060 7474
or email us
